Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus

Journal of Medicinal Chemistry

Volumn 48, Issue 4, 2005, Pages 1256-1259

  Hoever, Gerold ^a   Baltina, Lidia ^b   Michaelis, Martin ^a   Kondratenko, Rimma ^b   Baltina, Lia ^b   Tolstikov, Genrich A ^b   Doerr, Hans W ^a   Cinatl Jr , Jindrich ^a  

^a GOETHE UNIVERSITY   (Germany)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; GLYCOSIDE; GLYCYRRHIZIC ACID DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; GLYCYRRHIZA; IMMUNOCYTOCHEMISTRY; NONHUMAN; SARS CORONAVIRUS; VERO CELL; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; GLYCYRRHIZIC ACID; SARS VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VERO CELLS; VIRUS REPLICATION;

EID: 13944251304     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0493008     Document Type: Article

References (29)

1. Shibata, S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi. 2000, 120, 849-62.
2. Lin, J. C. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res. 2003, 59, 41-7.
3. Lampi, G.; Deidda, D.; Pinza, M.; Pompei, R. Enhancement of anti-herpetic activity of glycyrrhizic acid by physiological proteins. Antiviral Chem. Chemother. 2001, 12, 125-31.
4. Crance, J. M.; Scaramozzino, N.; Jouan, A.; Garin, D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res. 2003, 58, 73-9.
5. Sasaki, H.; Takei, M.; Kobayashi, M.; Pollard, R. B.; Suzuki, F. Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients. Pathobiology 2003, 70, 229-36.
6. Miyake, K.; Tango, T.; Ota, Y.; Mitamura, K.; Yoshiba, M.; Kako, M.; Hayashi, S.; Ikeda, Y.; Hayashida, N.; Iwabuchi, S.; Sato, Y.; Tomi, T.; Funaki, N.; Hashimoto, N.; Umeda, T.; Miyazaki, J.; Tanaka, K.; Endo, Y.; Suzuki, H. Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis. J. Gastroenterol. Hepatol. 2002, 17, 1198-204.
7. Yanagawa, Y.; Ogura, M.; Fujimoto, E.; Shono, S.; Okuda, E. Effects and cost of glycyrrhizin in the treatment of upper respiratory tract infections in members of the Japanese Maritime Self-Defense Force: Preliminary report of a prospective, randomized, double-blind, controlled, parallel-group, alternate-day treatment assignment clinical trial. Curr. Ther. Res. 2004, 65, 26-33.
8. Cinatl, J.; Morgenstern, B.; Bauer, G.; Chandra, P.; Rabenau, H.; Doerr, H. W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003, 361 (9374), 2045-6.
9. Haiying, L.; Na, H.; Xiaoyuan, X. The curative effects of glycyrrhizin on patients with SARS. Presented at the Annual Meeting of The Society of Infectious and Parasitic Diseases, Chinese Medical Association, Wuhan, China, Oct 18-22, 2003.
10. Wu, C. Y.; Jan, J. T.; Ma, S. H.; Kuo, C. J.; Juan, H. F.; Cheng, Y. S.; Hsu, H. H.; Huang, H. C.; Wu, D.; Brik, A.; Liang, F. S.; Liu, R. S.; Fang, J. M.; Chen, S. T.; Liang, P. H.; Wong, C. H. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (27), 10012-7.
11. Baltina, L. A. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr. Med. Chem. 2003, 10, 155-71.
12. Kondratenko, R. M.; Baltina, L. A.; Mustafina, S. R.; Vasil'eva, E. V.; Pompei, R.; Deidda, D.; Plyasunova, O. A.; Pokrovskii, A. G.; Tolstikov, G. A. The Synthesis and antiviral activity of glycyrrhizic acid conjugates with α-D-glucosamine and some glycosylamines. Russian J. Bioorg. Chem. 2004, 30, 275-282.
13. Baltina, L. A.; Ryzhova, S. A. M.; Vasil'eva, E. V.; Tolstikov, G. A.; Sakhautdinova, G. M.; Zarudii, F. S. Transformations of glycyrrhizic acid. VIII. Synthesis of immunomodulating glycopeptides using tert-butyl esters of amino acids. Russian J. Bioorg. Chem. 1994, 20, 778-784.
14. Baltina, L. A.; Ryzhova, S. A.; Vasil'eva, E. V.; Tolstikov, G. A. Transformations of glycyrrhizic acid. VII. Synthesis of triterpene glycopeptides containing alkyl esters of L-amino acids. Khim. Prir. Soedin. 1994, 20, 261-268.
15. Kondratenko, R. M.; Baltina, L. A.; Vasil'eva, E. V.; Baltina, L. A., Jr.; Ismagilova, A. F.; Nasyrov, K. M.; Baschenko, N. Z.; Kireeva, R. M.; Friedman, S. M.; Tolstikov, G. A. Synthesis and immunostimulating activity of cysteine-containing derivatives of glycyrrhizic acid. Russian J. Bioorg. Chem. 2004, 30, 61-67.
16. Baltina, L. A.; Ryzhova, S. A.; Vasil'eva, E. V.; Tolstikov, G. A. Transformations of glycyrrhizic acid. IV. Synthesis of triterpene glycopeptides. Russian J. Bioorg. Chem. 1994, 20, 40-46.
17. Baltina, L. A.; Sedyuk, N. G.; Flekhter, O. B.; Vasil'eva, E. V.; Tolstikov, G. A. Transformations of glycyrrhizic acid. The synthesis of 3-O-[β-6′-deoxy-6′-ammo-D-glucopyranosyl(1-2) -β-6″deoxy-6″-amino-D-glucopyranosido]-(3β,20β) -11-oxo-20-methoxycarbonyl-18β-olean-12-en-3-ol. Mendeleev Commun. 1995, 5, 178-179.
18. Baltina, L. A.; Vasil'eva, E. V.; Davydova, V. A.; Ismagilova, A. f.; Zarudii, F. S.; Tolstikov, G. A. Synthesis and pharmacological properties of a series of new heterocyclic and aromatic amides of glycyrrhizic acid. Pharm. Chem. J. 1996, 30, 503-506.
19. Kondratenko, R. M.; Mustafina, S. R.; Baltina, L. A.; Vasil'eva, N. G.; Ismagilova, A. F.; Vasil'eva, E. V.; Nasyrov, Kh. M.; Galin, F. Z.; Tolstikov, G. A. Synthesis and antiulcer activity of 3-O-acylated glycyrrhetic acid methylates. Pharm. Chem. J. 2001, 35, 243-246.
20. Davis, B. G. Recent development in glycoconjugates. J. Chem. Soc. 1999, 1, 3215-3237.
21. Lai, M. M.; Holmes, K. V. Coronaviridae: The viruses and their replication. In Fields Virology, 4th ed.; Knipe, D. M., Howley, Eds.; Lippincot Williams and Wilkins: Philadelphia, 2001; pp 1163-1168.
22. Sui, J.; Li, W.; Murakami, A.; Tamin, A.; Matthews, L. J.; Wong, S. K.; Moore, M. J.; Tallarico, A. S.; Olurinde, M.; Choe, H.; Anderson, L. J.; Bellini, W. J.; Farzan, M.; Marasco, W. A. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 2536-41.
23. Wang, Z. Y.; Nixon, D. W. Licorice and cancer. Nutr. Cancer 2001, 39, 1-11.
24. Rao, B. N.; Anderson, M. B.; Musser, J. H.; Gilbert, J. H.; Schaefer, M. E.; Foxall, C.; Brandley, B. K. Sialyl Lewis X mimics derived from a pharmacophore search are selectin inhibitors with anti-inflammatory activity. J. Biol. Chem. 1994, 269, 19663-6.
25. Francischetti, I. M.; Monteiro, R. Q.; Guimaraes, J. A.; Francischetti, B. Identification of glycyrrhizin as a thrombin inhibitor. Biochem. Biophys. Res. Commun. 1997, 235, 259-63.
26. Kondratenko, R. M.; Baltina, L. A.; Mustafina, S. R.; Makarova, N. V.; Nasyrov, Kh. M.; Tolstikov, G. A. Crystalline glycyrrhizic add synthesized from commercial glycyrrham. Immunomodulant properties of high-purity glycyrrhizic acid. Pharm. Chem. J. 2001, 35, 101-104.
27. Baltina, L. A.; Ryzova, S. A.; Vasiljeva, E. V.; Tolstikov, G. A. Transformations of glycyrrhizic acid. VI. New method of preparation of carboxy-protected glycopeptides. J. Obshch. Khim. 1994, 20, 55-62.
28. Drosten, C.; Gunther, S.; Preiser, W.; van der Werf, S.; Brodt, H. R.; Becker, S.; Rabenau, H.; Panning, M.; Kolesnikova, L.; Fouchier, R. A.; Berger, A.; Burguiere, A. M.; Cinatl, J., Jr.; Eickmann, M.; Escriou, N.; Grywna, K.; Kramme, S.; Manuguerra, J. C.; Muller, S.; Rickerts, V.; Sturmer, M.; Vieth, S.; Klenk, H. D.; Osterhaus, A. D.; Schmitz, H.; Doerr, H. W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003, 348, 1967-76.
29. Hoever, G.; Groeschel, B.; Chandra, P.; Doerr, H. W.; Cinatl, J., Jr. The mechanism of 3′-azido-2′,3′-dideoxythymidine resistance to human lymphoid cells. Int. J. Mol. Med. 2003, 11, 743-7.